NUAGE THERAPEUTICS
LIVE

Serial Number

79370637

Owner

Nuage Therapeutics, S.L.

Attorney

Lawrence Apolzon

Filing Date

Nov 25, 2022

Add to watchlist:

No watchlists yet
View on USPTO

NUAGE THERAPEUTICS Trademark

Serial Number: 79370637 • Registration: 7459228

NUAGE THERAPEUTICS is a trademark filed by Nuage Therapeutics, S.L. on November 25, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Nuage Therapeutics, S.L. (2 trademarks)

Baldiri Reixac 10-12

Entity Type: 99

Trademark Details

Filing Date

November 25, 2022

Registration Date

July 30, 2024

Published for Opposition

May 14, 2024

Goods & Services

Custom manufacture of cell lines for use in the manufacture of biopharmaceutical products; custom manufacture of proteins for third parties; custom manufacture of medicines; custom manufacture of biopharmaceuticals

Pharmaceutical preparations for targeting of disordered proteins; chemical, analytical and diagnostic reagents for in vitro medical or veterinary use; chemical reagents for medical use; chemical reagents for use in medical or veterinary diagnostics; pharmaceutical preparations for use in the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of ophthalmic diseases and conditions and for the treatment of inflammation and inflammatory conditions and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for the prevention and treatment of immune-related, neurological and neurodegenerative diseases

Scientific, medical, and medical industrial research and development services; medical clinical research studies; laboratory medical research; research and development of new drugs and medical clinical products; analysis of materials; chemical analysis; medical and scientific laboratory services; laboratory medical testing services; medical laboratory services; information and advisory services relating to the aforesaid, including such services provided online from a computer network or via the internet; research and development services for pharmaceutical preparations and for the treatment of diseases and injuries; genetic engineering services; genetic research for scientific or medical purposes; scientific research and development; scientific research in the field of genetics; medical and pharmacological research services; research and development in the fields of biotechnology, biopharmaceuticals, and gene therapies; medical and scientific research, namely conducting clinical trials; research and development of pharmaceutical products; research and development of vaccines and medicines; stem cell research; research and development in the fields of microorganisms and cells; research in the field of gene therapies; advisory services relating to gene therapy research; biological research, clinical medical research and medical research; product development; biological product development services; consultancy relating to pharmaceutical research and development; providing scientific information in the field of medical disorders and their treatment; pharmaceutical research and development; scientific services relating to the isolation and cultivation of human tissues and cells; research related to molecular science; analysis in the field of molecular biology; research services relating to molecular sciences

Chemicals for use in product development in the fields of science, scientific research and for laboratory use; in vitro analytical and diagnostic reagents for scientific use

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 15, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 28, 2025 FICS
FINAL DISPOSITION PROCESSED
Jan 28, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 30, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 30, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 30, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 14, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 14, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 5, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 28, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 27, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 27, 2024 TROA
REFUSAL PROCESSED BY IB
Oct 17, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 27, 2023 RFCS
REFUSAL PROCESSED BY MPU
Sep 27, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 9, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 8, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 6, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
May 30, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 26, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 25, 2023 REPR